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Abstract
Histone lysine methylation (Kme) encodes essential information modulating many biological
processes including gene expression and transcriptional regulation. However, the atomic-level
recognition mechanisms of methylated histones by their respective adaptor proteins are still
elusive. For instance, it is unclear how L3MBTL1, a methyl-lysine histone code reader, recognizes
equally well both mono- and di-methyl marks, but ignores unmodified and trimethylated lysine
residues. We made use of Molecular Dynamics (MD) and Free Energy Perturbation (FEP)
techniques in order to investigate the energetics and dynamics of the methyllysine recognition.
Isothermal Titration Calorimetry (ITC) was employed to experimentally validate the
computational findings. Both computational and experimental methods were applied to a set of
designed “biophysical” probes that mimic the shape of a single lysine residue and reproduce the
binding affinities of cognate histone peptides. Our results suggest that, besides forming favorable
interactions, the L3MBTL1 binding pocket energetically penalizes both methylation states and has
most probably evolved as a “compromise” that non-optimally fit to both mono- and di-methyl-
lysine marks.
Introduction
Histone lysine-methylation plays a key role in transcriptional regulation1. Abnormal
methylation patterns may lead to various pathologies including cancer2,3. At the molecular
level, methylation marks act via recruitment of protein complexes that mediate
transcriptional activation or repression4. MBT repeats form the smallest and the least studied
class of “chromatin readers”, i.e. protein modules that bind to methyl-lysine marks on
histone tails. Functionally, these proteins localize to chromatin and regulate transcription by
a currently unknown molecular mechanism5. For instance, L3MBTL1, a protein that
features three MBT domains, recognizes mono- and di-methyl-lysine marks on H1.4K26,
H3K4, H3K9, H3K27 and H4K20 in vitro and associates with Heterochromatin Protein 1
(HP1γ), and the Retinoblastoma protein (Rb)6. These interactions result in a transcriptionally
nonpermissive chromatin structure in vitro and the negative regulation of multiple genes
through the E2F/Rb oncogenic pathway7,8. Remarkably, despite the complexity of the
L3MBTL1 interaction network, it has been demonstrated that transcriptional repression by
L3MBTL1 relies upon a single methylation mark (H4K20me1)9. Moreover, the lower
Corresponding author: Dmitri Kireev Center for Integrative Chemical Biology and Drug Discovery University of North Carolina at
Chapel Hill Campus Box 7363, Genetic Medicine Building, room 2097 120 Mason Farm Road Chapel Hill, NC, 27599-7363 Office:
(919) 843-8457 Fax: (919) 843-8465 dmitri.kireev@unc.edu .
Supporting Information: Supplementary Schemes; Supplementary Tables; Binding Curves for ITC Experiments; Experimental
Procedures for all new compounds. This material is available free of charge via the Internet at http://pubs.acs.org.
NIH Public Access
Author Manuscript
J Am Chem Soc. Author manuscript; available in PMC 2012 April 13.
Published in final edited form as:













methylation state specificity of L3MBTL1 was exclusively mediated by the second MBT
domain9.
Although the biological implications of the various histone methylation states are subject to
intense investigations5, the atomic-scale energetics and dynamics of Kme recognition by
respective histone code readers remain elusive. Yet, exogenous modulation of the histone
code using small molecule agents will require a detailed understanding of how lysine
methylation states are recognized by their respective adaptor proteins. More specifically, it
is unclear how adding a single methyl group to Kme0 or removing it from Kme3 results in a
huge gain in affinity to a “reader” protein, while adding a methyl to Kme1 does not affect
the affinity at all.
Free Energy Perturbation (FEP)10, coupled to Molecular Dynamics (MD) simulations, is
well suited to study energetics and dynamics at the atomic level. Moreover, valuable
additional information, such as electrostatic or van der Waals (vdW) contributions to the
free energy of binding can also be extracted from computational simulations. Obtaining this
valuable information requires a judicious choice of a study system. Ideally, the potential
energetic changes should be confined to the interaction between the methylated lysine side
chain and the “reading” pocket of L3MBTL1. Although straightforward in silico, this
approach may appear less biologically relevant than previously reported experimental
studies6,7,11 involving 10-15 residue histone fragments. However, a substantial body of
evidence demonstrates that such a reductionist hypothesis (that biological function relies
upon a localized pocket-residue interaction) is applicable in the context of Kme recognition
by L3MBTL1. For instance, it has been shown that the MBT-Kme recognition occurs in a
histone sequence independent manner6,7,11. Moreover, available X-ray structures of MBT-
containing proteins demonstrate a “cavity-insertion” recognition mode, with the modified
lysine side-chain fully buried within the MBT binding cage4, while the rest of the histone
chain is exposed to the solvent and forms very low-impact interactions with the reader
protein. Finally, the reductionist hypothesis is also supported by cell-based data. More
specifically, it has demonstrated that repressive function of L3MBTL1 relies solely on its
second MBT repeat and does not need its interaction partners (i.e. Rb and HP1γ)9. From the
computational perspective, the use of a monopeptide-like probe whose interactions would be
confined to the Kme binding pocket is also highly preferred because allows to avoid any
parasitic interactions that might occur between L3MBTL1 and a polypeptide probe.
Moreover, the smaller probes will have significant phase space overlaps, which will result in
a better convergence of FEP calculations12.
Here, in line with the above rationale, we investigate the atom-level energetics of MBT-Kme
recognition in a system where L3MBTL1 interacts with small molecules that mimic a single
lysine residue. Six compounds that we refer to as biophysical probes were synthesized. The
compounds 1-4 (Table 1; Supporting Information) demonstrate the same affinity profile
towards L3MBTL1 as cognate peptides do. To gain a deeper understanding of the
L3MBTL1 binding pocket architecture we have also synthesized and studied two exogenous
alkylated lysine analogs, compounds 5 (N(me)et) and 6 (pyrrolidine). In order to corroborate
computational findings with experimentally observable data, we measured the affinity of the
designed biophysical probes to L3MBTL1 by means of Isothermal Titration Calorimetry
(ITC).
Results and Discussion
At the first step, we studied binding of all six synthesized compounds to a fragment of
L3MBTL1 consisting of three MBT domains (residues 200-522) by means of ITC. The
results (Table 1, Supplementary Figures) suggest that the probes, with exception of
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compounds 1 (Nme0) and 4 (Nme3), demonstrate a dose-dependent interaction with
affinities in the order pyrrolidine > Nme2 ≈ N(me)et ≈ Nme1 >> Nme3 ≈ Nme0. The
relative order and absolute binding free energies of the studied compounds are consistent
with the trend observed for histone peptides, which supports their use as biophysical probes
to study MBT-Kme recognition. In order to make sure that our probes do actually bind to the
second MBT domain of L3MBTL1 we have also measured binding of compounds 2, 3, 5
and 6 to the D355A L3MBTL1 mutant. This mutation has previously been demonstrated to
efficiently switch off any binding of mono- or di-methylated histones6 because of the
absence of the main binding anchor Asp355. Our ITC experiments with the mutant did not
show any measurable binding (Supplementary ITC figures). This strongly supports the
hypothesis that the studied compounds bind to the lysine binding pocket of the second MBT
domain.
Our experimental affinity data confirm the intriguing structure-activity relationships (SAR),
where the same chemical modification, i.e. adding or removal of a single methyl group, in a
similar context, may result either in no change in affinity or in its full loss. More
specifically, it is unclear how adding a single methyl group to Nme0 or removing it from
Nme3 results in a huge gain in affinity to a “reader” protein, but does not affect the affinity
when adding a methyl to Nme1. Consequently, we performed a series of FEP and MD
simulations (see Methods and Supplementary Scheme 1a) in order to provide an atomic-
scale structural rationale for these “atypical” SAR. The computed free energies obtained
demonstrate a strong correlation with ITC results, which justifies the use of FEP for the
energetic analysis of Kme recognition.
The same computational protocol was also used to determine relative weight of polar and
non-polar contributions to the binding affinity and to ascertain “preferred” interaction modes
for each compound. To this end, we made use of virtual probes that represent neutral
isomorphs of compounds 1-6 obtained by replacing their amino nitrogens with carbon
atoms. As previously demonstrated13-15, the binding free energy difference between an
ionizable compound and its respective non-polar isomorph ( ) can be exclusively
attributed to polar interactions, i.e. hydrogen bonding, cation-π and long range ionic
interactions (see Methods and Supplementary Scheme. 1b). Furthermore, the nonpolar
contribution to the difference in affinities of two compounds can be expressed as the
difference in affinities of the two respective nonpolar isomorphs. Here, we performed six
additional FEP calculations to compute relative binding affinities of neutral isomorphs 1′-6′
to L3MBTL1 (see Table 1) and used these affinities in the further energetic and structural
analyses.
We first compared data obtained for compounds 2 (Nme1) and 3 (Nme2). Their respective
affinities to L3MBTL1 were similar in both ITC and FEP experiments. However, binding
free energies of their respective neutral isomorphs 2′ and 3′ are significantly different
(Scheme 1, Supplementary Scheme 2). The neutral isomorph 2′ binds tighter than 3′ by 1.10
kcal/mol due to its more efficient non-polar interactions. Additionally, we made use of
conventional MD simulations to provide a structural interpretation for the MBT-Nme
recognition. Ten thousand structural snapshots from 20 ns simulations were clustered and
analyzed in order to determine the most representative bound ligand conformations. As
shown in Figure 1a, the bound state of compound 2 (Nme1) may be represented by 5
conformations, varying significantly in positions of both the amino nitrogen and the methyl
group. However, despite its high mobility within the binding pocket, the only methyl group
of compound 2 manages to keep optimal distances of ca. 3.5 Å to each of three aromatic
side chains, Phe379, Trp382 and Tyr386 (see Methods and Fig. 2). In contrast, the bound
compound 3 (Nme2) is represented by three quite distinct orientations of its methyl groups
(Fig. 1b). The distance distribution in Fig. 2 shows that only one methyl group can keep an
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optimal distance to the aromatic side chains, while the other can significantly diverge
beyond the range of optimal vdW interactions. One of representative conformers of
compound 3 is identical to the X-ray conformation of Kme2 with L3MBTL111 and two
others differ only in methyl group orientations while keeping the amino nitrogen in a
position of optimal electrostatic interaction with Asp355.
Therefore, both structurally and energetically, the identical binding affinities of 2 (Nme1)
and 3 (Nme2) are achieved through quite different recognition mechanisms (as depicted in
Fig. 3). Most remarkably, both methylation forms are moderate-affinity MBT binders. For
instance, compound 2 (Nme1) benefits from more efficient vdW interactions and a higher
bound-state mobility, leading to a favorable entropic contribution. However, it is penalized
by suboptimal electrostatic interactions because its positive charge is delocalized between
two hydrogens of which only one can efficiently interact with the carboxyl group of Asp355.
Alternatively, the compound 3 (Nme2) is penalized by less favorable non-polar interactions,
but benefits from a much stronger electrostatic contribution due to its highly localized
positive charge. Consequently, it appears that the lysine pocket of L3MBTL1 that equally
non-optimally binds both cognate ligands (i.e. Kme1 and Kme2) has emerged as an
evolutionary “compromise” between two possible pocket designs, each of which would
tightly bind either Kme1 or Kme2. Energetically, this “compromise” pocket equally
penalizes both methylation states, although through different interaction forces.
The proposed “compromise” pocket hypothesis is also compatible with the extremely weak
affinity of compounds 1 (Nme0) and 4 (Nme3). Indeed, compounds 1 (Nme0) lacks all
favorable vdW interactions, from which its closest analog 2 (Nme1) benefits. This results in
a non-polar free energy loss of 2.90 kcal/mol. Furthermore, compound 1 (Nme0) is also
penalized by a weaker electrostatic contribution because its positive charge is delocalized
between three hydrogen atoms, resulting in a loss of an additional 1.83 kcal/mol. As to the
low affinity of compound 4 (Nme3), it has been previously hypothesized that steric
repulsion is the major force preventing MBT domains from binding the trimethylated
lysine4. Our decomposition analysis suggests that while the non-polar term (0.73 kcal/mol)
penalizes compound 4, the polar term (1.38 kcal/mol) is even more important for the decline
of its affinity (relative to 3). The above is in agreement with the observation that a
negatively charged residue is essential for a functional MBT domain, but not mandatory for
a Kme3 binding domain4. For example, the Kme3 binding pocket of BPTF, a PHD finger-
containing protein, does not contain any acidic residues; interestingly, a Y17E mutation in
the binding pocket led to BPTF preferentially recognizing Kme2 over Kme36.
Finally, in line with the finding that the native methylation state binding is imperfect by
design, one might also infer that a tighter MBT binder is possible. To test this hypothesis we
have synthesized and studied two alkylated lysine analogs 5 (N(me)et) and 6 (pyrrolidine),
whose ability to bind MBT domains was established in our previous studies16,17. ITC data
show that compound 6 is the most potent of all alkylation states we have examined and
binds tighter than 3 (Nme2) by 0.66 kcal/mol, while the potency of compound 5 (N(me)et) is
comparable to that of 3 (Nme2). Our free energy decomposition analysis suggests that the
calculated gain in affinity of 6 (pyrrolidine) over 3 (Nme2) (1.51 kcal/mol), is due to a huge
electrostatic contribution of 2.75 kcal/mol. Compound 6 is however penalized for its two
extra carbons by a non-polar penalty of 1.23 kcal/mol compared to 3. On the atomic level,
the significant electrostatics-related advantage of 6 is hard to explain considering a relatively
modest change in partial charge as compared to 3 (Nme2). To further examine this
interaction, we analyzed the conventional MD trajectory to provide a structural rationale for
the apparent electrostatics reward. The analysis demonstrates that the pyrrolidine ring,
slightly withdrawn from the pocket, has a very low mobility in its bound state and is
constrained to optimally interact with Asp355 (Fig. 1d). Moreover, the pyrrolidine ring is
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parallel to the aromatic side chain of Trp382 and forms an aromatic-aliphatic ring stacking
motif, commonly seen in the Cambridge Structure Database18 and in some proteins
featuring an aromatic binding cage19.
To conclude, in this study we proposed the L3MBTL1 lysine binding pocket has evolved as
a “compromise” that features equally non-optimal fits to both mono-and demethylation
states. This finding may help in understanding the evolutionary development of the
methylation machinery and also provide guidance to the development of more efficient
exogenous modulators of the histone code.
Experimental section
Synthesis
Detailed synthetic procedures and characterization are described in the supporting
information.
Protein and ligand structure preparation for MD and FEP
We used the second MBT domain (residues 366 to 424) of the X-ray structure of L3MBTL1
at 2.05 Å resolution (PDB entry: 2RJF)11 as a starting point for all MD/FEP simulations.
The protein structure was prepared using Protein Preparation Wizard from the Maestro
software suite20. Hydrogen atoms were added to the structure and the whole system was
minimized using the OPLS force field21. Three-dimensional structures of small-molecule
ligands were generated with Ligprep20, and multiple low energy conformations were saved.
To obtain initial binding poses, all ligands were docked to the protein using Glide’s Standard
Precision (SP) mode22. These binding poses were visually inspected and the most
reasonable structure was selected as the initial bound structure for dynamic simulation. No
acceptable docking pose was found for compound 4 (Nme3). Its initial bound structure was
obtained by superimposing it to compound 3 (Nme2), followed by a local minimization. All
simulation systems were solvated in an orthorhombic TIP3P water box with a minimum of
10 Å between the box boundary and any solute atom.
Molecular Dynamics
Molecular dynamics was employed to sample the system ensembles during FEP calculation.
AMBER99SB force field23 was used to describe the receptor. This force field has been
proven to efficiently reproduce the cation-π interaction24, which is crucial for our model
system. It is also recently applied to investigate the methyl-lysine dependent binding of H3
histone tails to the HP1 chromodomain14. General Amber Force Field (GAFF)25 was used to
model ligand molecules. Atomic partial charges were derived by restrained electrostatic
potential (RESP)26 method, using geometries optimized at HF/6-31G* level in Gaussian
0327.
All MD simulations were conducted using Desmond v2.228,29. Particle mesh Ewald (PME)
summation was used to treat long-term interactions30. SHAKE algorithm31 was used to
restrain all bonds involving hydrogen atoms. The system was energy-minimized and then
gradually heated to 300 K during 0.5 ns. An additional 1.0 ns simulation at 300 K was
performed to further equilibrate the system. All production runs were performed with the
NPT ensemble. System temperature and pressure were regulated by Langevin thermostat
and barostat32. The integration time steps were 1 fs, 1 fs, 3 fs for, respectively, the bonded
term, the near term (short-range electrostatic and van der Waals interactions) and the far
term (long range electrostatic interactions).
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Binding free energy differences (ΔΔGi→j) for two similar ligands i and j that bind to the
same protein were calculated by means of the FEP method according to the thermodynamic
cycle shown in Supplementary Scheme 1a. Relative binding affinities ΔΔGi→j was
computed by calculating the free energy difference of two ligands in solution and in protein,
where:
Alchemical mutations were performed on a dual topology basis, comprising a series of
intermediate states. To speed up the convergence, soft-core potential was used to scale down
the vdW potential. For a simulation window k, the hybrid Hamiltonian was the sum of
Lennard-Jones, electrostatic and bonded interaction terms:
where λk is a coupling parameter between the initial and final Hamiltonians. Most FEP
simulations involved a total of 17 windows, with an 8.0 ns production run in each window.
The λk values used in our calculations were listed in Supplementary Table 1. To ensure a
smooth alchemical transformation from compounds 5 (N(me)et) to 6 (pyrrolidine),
simulations were performed on a 23 window basis, with three additional windows in the
beginning of the simulation and three in the end.
For each system, two independent calculations with different random seeds were performed.
Results from both simulations were combined and subjected to the Bennett acceptance ratio
(BAR) analysis33 in order to compute free energy differences between every two adjacent
simulation windows. The block bootstrapping method was used to estimate the statistical
uncertainties34. In this study, 20 block bootstrapping trials were conducted and the standard
errors over these trials were reported in Supplementary Table 2.
Free energy decomposition
The binding site of the second MBT domain of L3MBTL1 features an aromatic cage and an
aspartate residue. Hence, the interaction with cationic lysine-like ligands may involve ionic,
hydrogen bonding, cation-π and vdW interactions. MD/FEP simulations allow to determine
the energetic components of the ligand-protein binding. More specifically, virtual non-polar
isomorphs of the actual ligands have proved a useful tool to decompose the relative free
energy of binding ΔΔGi→j into electrostatic and non-polar contributions14,35. The
electrostatic term mainly includes hydrogen bonding, cation-π and long range ionic
interactions, while the non-polar contribution is often referred to as a charge-independent
term, including van der Waals interactions and the hydrophobic effect. Here we performed
six FEP calculations to compute the relative binding affinities between our polar compounds
1-6 and their respective non-polar isomorphs 1′-6′ (e.g., the non-polar isomorph for Nme3 is
Cme3). These calculations completed the thermodynamic cycle showed in Supplementary
Scheme 1b. Because the nonpolar compounds have an identical size and shape to their
corresponding polar counterparts, the relative binding free energy between each two neutral
isomorphs (ΔΔGi’→j’ in Supplementary Scheme 1b) can be used to estimate the non-polar
effect during the binding of the charged compounds i and j. On the other hand, the
difference between ΔΔGi’→j’ and the relative binding free energy of the polar compounds
ΔΔGi→j can be considered as the electrostatic contribution (ΔΔGi→j–ΔΔGi’→j’ in
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Supplementary Scheme 1b). The decomposed free energies are summarized in Scheme 1
and Supplementary Scheme 2.
Representative MD conformations
In order to provide structural insights into the Kme recognition mechanism we selected
representative ligand-protein conformations from MD simulations. To this end, we
performed conventional 20 ns MD simulations for each protein-ligand complex. System
coordinates were saved every 2 ps, yielding 10,000 snapshots per MD run. The snapshots
were then clustered based on the distances from the ligand’s heavy atoms to the aromatic
residues that constitute the active site. Clustering was performed using Pipeline Pilot v7.536.
The final representative structures were obtained by a visual inspection of all cluster centers.
General Procedure for Isothermal Titration Calorimetry (ITC) Experiments
For the ITC measurements, L3MBTL1 was extensively dialyzed into ITC buffer (20 mM
Tris-HCl, pH 8, 25 mM NaCl and 2 mM β-mercaptoethanol). Subsequently, the
concentration was spectrometrically established; the extinction coefficient ε for L3MBTL1
is 90870. The ITC experiments were performed at 25°C, using an AutoITC200
microcalorimeter (MicroCal Inc., USA). Experiments were performed by injecting 1.5 μl of
a 1 mM solution of the compounds into a 200 μL sample cell containing 50 μM or 100 μM
L3MBTL1: all weakly binding compounds 2, 3 and 5 were titrated to a 100 μM protein
solution, compounds 1, 4 and 6 was titrated to 50 μM protein. A total of 26 injections were
performed with a spacing of 180 seconds and a reference power of 8 μcal/s. Compounds
were dissolved in ITC buffer at 10 mM and were diluted to 1 mM. A control experiment for
each compound was also performed and the heat of dilution was measured by titrating each
compound into the buffer alone. The heat of dilution generated by the compounds was
subtracted, and the binding isotherms were plotted and analyzed using Origin Software
(MicroCal Inc., USA). The ITC measurements were fit to a one-site binding model.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Free energy decomposition for compounds 1-6 (as annotated in Table 1). P / NP refer
respectively to polar and non-polar contribution to ΔΔGFEP.
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Representative conformers of compounds 2, 3 and 6 derived from a 20 ns MD simulation in
the Kme binding site of L3MBTL1: a) compound 2 (Nme1) demonstrates a high
conformational diversity, b) compound 3 (Kme2) features 3 distinct orientations of its
methyl groups, c) the pyrrolidine group of 6 is fixed in the cage allowing only for the carbon
chain flexibility, d) superposition of most frequent orientations of Nme1, Nme2 and
pyrrolidine heads.
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Distance distributions between the methyl groups of biophysical probes and aromatic side
chains of the binding pocket of L3MBTL1. The only methyl group of compound 2 (Nme1,
red curve) is most of the time in the distance range corresponding to the optimal vdW
interactions. Only one of two methyl groups of compound 3 (Nme2, blue curves) manages
to keep an energetically favorable distance to the aromatic side chains.
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A qualitative recognition model of various lysine methylation states by MBT domains. The
Nme0 state demonstrates weak interactions to all binding site residues, while Nme3 is
lacking a critical interaction with Asp355. The Nme1 and Nme2 states display the same
binding affinity, but quite different interaction patterns.
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